January 4, 2022
Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices The collaboration will explore the uptake and actionability of comprehensive genomic profiling in patients with advanced cancers. San Francisco, CA – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases [...]
Alamar Biosciences partners with Abcam to drive understanding of the human proteome
January 4, 2022
Alamar selects Abcam as a key provider of antibody content for its propriety NULISA technology platform Fremont, CA, US and Cambridge, UK – Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, [...]
GeneASIC Applied sciences to Exhibit New Genome Knowledge Evaluation System at CES 2022
January 4, 2022
LAS VEGAS — GeneASIC Applied sciences might be strolling into this 12 months’s CES 2022 arm in arm with its first product, the GeneASIC Subsequent-Technology Sequencing Evaluation Acceleration Platform (NGSAAP). The annual occasion deemed probably the most influential tech occasion and is a showcase of the most recent innovation in design and engineering within the client know-how [...]
January 4, 2022
The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, interpret, and report genomic variants, and will be able to utilize the power of proprietary reagent kits CENTOGENE is developing in collaboration with Twist Bioscience for rare disease diagnostics CentoCloud provides rapid and reliable medical [...]
eureKARE participates in DNA Script’s $200 Million Series C Financing
January 4, 2022
eureKARE participatesin DNA Script’s $200 Million Series C Financing Fundraisewill accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France – eureKARE ("the Company"), a pioneering company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, is pleased to announce that it has participated in DNA Script’s [...]
January 4, 2022
CAMBRIDGE, Mass. -- Erbi Biosystems, developer of innovative, small-scale, automated, and high-performance cell culture systems, has closed a private round of funding totaling $4M. This latest financing will enable the company to expand operations to meet the growing demand for its Breez perfusion bioreactor product and develop extensions to enhance cell therapy applications. The Erbi Breez bioreactor provides [...]
908 Devices and U.S. Forest Service Announce Development Collaboration
January 4, 2022
BOSTON -- 908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, and the United States Forest Service (USFS), an agency of the United States Department of Agriculture (USDA), are collaborating on a research effort to extend the capabilities of the MX908 handheld device for rapid detection of toxic pesticides used in illegal marijuana grows [...]
Haier Biomedical TwinCool ULT Freezer Preferred by Labs at Washington University in St Louis
January 4, 2022
Recently, the Finck Lab and Davidson Lab at Washington University in St Louis procured Haier Biomedical TwinCool ULT freezers to meet the strict requirements for temperature and safety of sample storage during experiments. Haier Biomedical’s TwinCool ULT freezer is known for its safety, security, and reliability, hence the decision by the University to procure. The [...]
BBI Solutions completes Acquisition of BioTeZ Berlin-Buch GmbH
January 4, 2022
BBI Solutions, the world’s leading independent provider of immuno-diagnostic reagents and contract services, has today announced the acquisition of “Biotez”. BioTeZ Berlin-Buch GmbH (also including Steffens Biotechnische Analysen GmbH), is a Germany-based manufacturer of reagents and finished tests for the In-Vitro Diagnostics (“IVD”) market, as well as components for the food safety market. The acquisition [...]
CRAIC Technologies Introduces the 2030PV PRO™ UV-visible-NIR Microspectrophotometer
January 3, 2022
CRAIC Technologies introduces 2030PV PRO™, a system able to acquire spectra of microscopic samples throughout the UV-visible-NIR region in absorbance, reflectance, fluorescence and photoluminescence. The system can even be equipped to measure Raman microspectra™. SAN DIMAS, CA, UNITED STATES -- CRAIC Technologies, the worlds leading innovator of UV-visible-NIR microspectroscopy solutions, is proud to introduce the [...]

